
ali karagoz
@alikaragozmd
Cardiologist,
ID: 563968979
26-04-2012 19:19:14
449 Tweet
823 Followers
1,1K Following


Venk Murthy MD PhD Bogdan Enache SABOURETCardiologist Prof Darrel Francis ☺ Mk CardioFellows Great Again Andrew Althouse Andreas Bollmann I remember discussions about EXCEL trial. A respectable researcher (Gregg W. Stone MD) tried to answer all questions tirelessly. However, while EVAPORATE authors do not answer questions, one of them is so aggressive even to those who ask questions. So I don't believe their findings

Great meeting about methodology&stats of NOAC researchs in AF !!! over 400 participants 😉 Next meeting is on 10 November moderated by Jan Steffel I.H.Tanboga, MD, PhD Ilker Tekkesin, MD Göksel Çinier Can Yucel Karabay Fatoş Özkalayci Selim Topcu, MD, PhD ali karagoz Akhmetzhan Galimzhanov Mert İlker Hayıroğlu




Honored to be elected as #EAPCI national ambassador. A true privilege, looking forward for collaboration, new friends and projects on the horizon. ABaumbach William Harvey Research Institute Anthony Mathur Davide Capodanno Barts Interventional Group (B.I.G.) James moon Steffen Petersen Prof. Hector M. Garcia-Garcia Lorenz Räber, MD PhD Mamas A. Mamas


New ESC #HeartFailure Guidelines 2021. Immediate start of #ARNI + #BB + #MRA + #SGLT2i save lifes @ESCCongress2021 Turkish Society of Cardiology Mehmet Birhan YILMAZ 🇹🇷 Can Yucel Karabay Göksel Çinier European Society of Cardiology ali karagoz William Harvey Research Institute


REDUCE-IT PRIOR MI - significant reductions in cardiovascular death, cardiac arrest, and sudden cardiac death with icosapent ethyl.Turkish Society of Cardiology Can Yucel Karabay @cananelifyldz1 I.H.Tanboga, MD, PhD Taylan Akgün ilke European Society of Cardiology ali karagoz Bulent Mutlu


Have a look at this #ESCAbstract on the #ESCCongress Research Gateway cyim.page.link/fx9o European Society of Cardiology Vit D deficiency predicts the no-reflow phenomenon in STEMI patients undergoing pPCI Turkish Society of Cardiology ali karagoz Taylan Akgün Salvatore Brugaletta Vedat Aytekin Prof. Dr. Enver Atalar I.H.Tanboga, MD, PhD

EMPEROR-preserved trial in HFmrEF and HFpEF Empagliflozin reduced 21% CV mortality and HF hospitalization in composite endpoint but Dıdnot reduced all cause mortality #EMPERORpreserved European Society of Cardiology Vedat Aytekin Dr Meral Kayikcioglu Lale Tokgozoglu I.H.Tanboga, MD, PhD Can Yucel Karabay Bulent Mutlu



why reviewers are almost always obsessed and find it weird that regression coefficients using rcs are presented with IQR change. I'm tired answering. Frank Harrell I.H.Tanboga, MD, PhD Maarten van Smeden Gary Collins


Our paper has just been published in International Journal of Cardiovascular Imaging. link.springer.com/content/pdf/10… Maarten van Smeden Venk Murthy MD PhD @drmuratcap ali karagoz Doç. Dr. Emrah Erdoğan Cengiz Burak, MD, DRCPSC Muhammed Süleymanoğlu


Great to be back together with live events at the Advanced Therapies Summit, Istanbul. With attendees coming from more than 37 countries. Thanks to the chairpersons, faculty and speakers. #PioneeringTechnology #PCI #TAVI Prof Mamas Mamas Mamas A. Mamas Prof Karabay Can Yucel Karabay



Excited to work for PROGRESS-BIFURCATION registry with Emmanouil Brilakis , Deniz Mutlu and Barkın Kültürsay
